Mitochondrial dysfunction is an early prominent feature in susceptible neurons in the brain of patients with Alzheimer's disease, which likely plays a critical role in the pathogenesis of disease. Increasing evidence suggests abnormal mitochondrial dynamics as important underlying mechanisms. In this study, we characterized marked mitochondrial fragmentation and abnormal mitochondrial distribution in the pyramidal neurons along with mitochondrial dysfunction in the brain of Alzheimer's disease mouse model CRND8 as early as 3 months of age before the accumulation of amyloid pathology. To establish the pathogenic significance of these abnormalities, we inhibited mitochondrial fragmentation by the treatment of mitochondrial division inhibitor 1 (mdivi-1), a mitochondrial fission inhibitor. Mdivi-1 treatment could rescue both mitochondrial fragmentation and distribution deficits and improve mitochondrial function in the CRND8 neurons both in vitro and in vivo. More importantly, the amelioration of mitochondrial dynamic deficits by mdivi-1 treatment markedly decreased extracellular amyloid deposition and Ab 1-42 /Ab 1-40 ratio, prevented the development of cognitive deficits in Y-maze test and improved synaptic parameters. Our findings support the notion that abnormal mitochondrial dynamics plays an early and causal role in mitochondrial dysfunction and Alzheimer's diseaserelated pathological and cognitive impairments in vivo and indicate the potential value of restoration of mitochondrial dynamics as an innovative therapeutic strategy for Alzheimer's disease.
Introduction
Mitochondria play a crucial role in neuronal energy supply and calcium buffering (1) . They are dynamic organelles that undergo continuous fission and fusion regulated by a machinery involving large dynamin-related GTPases that exert opposing effects, homeostasis of mitochondria and changes in mitochondrial dynamics significantly impact almost all aspects of mitochondrial function including energy metabolism, calcium buffering, ROS generation and apoptosis regulation and also impacts the movement and the proper distribution of mitochondria within a cell (3, 4) . Indeed, defects in the mitochondrial fission/fusion balance and thus, the morphology and distribution have the potential to cause localized energy, calcium and/or redox imbalance, which is especially damaging to polarized cells such as neurons, resulting in cellular dysfunction and death (5, 6) . Not surprisingly, mutations in mitochondrial fission and fusion genes cause mainly human neurological diseases (6) .
Alzheimer's disease is a progressive neurodegenerative disorder of the elderly associated with declining memory and cognitive function. Defective glucose utilization and energy metabolism is one of the best documented abnormalities in Alzheimer's disease (7, 8) , suggesting that mitochondrial dysfunction is likely involved in the pathogenesis of Alzheimer's disease. Indeed, mitochondrial dysfunction is well documented as an early prominent feature of Alzheimer's disease neurons (9) ; however, the underlying mechanism remains elusive. Most recent studies from multiple groups, including ours, suggested that abnormal mitochondrial dynamics likely plays a critical role in mitochondrial dysfunction and neuronal dysfunction in Alzheimer's disease. Significant changes in mitochondrial size and number in vulnerable neurons in Alzheimer's disease (10) suggests that the normally strict regulation of mitochondria morphology is impaired. Indeed, such a notion is supported by the observation that mitochondrial fission/fusion proteins were differentially expressed and redistributed in pyramidal neurons in Alzheimer's disease hippocampal tissues (11) (12) (13) and that fibroblasts from Alzheimer's disease patients demonstrated significant alterations in mitochondrial morphology and distribution (14) . Interactions between DLP1 and Ab or phosphorylated s was reported in brain homogenates from Alzheimer's disease patients (13, 15) . Excessive mitochondrial fission and its deleterious effects are unequivocally demonstrated in in vitro models of Alzheimer's disease: overexpression of amyloid precursor protein (APP) or Ab treatment induces profound mitochondrial fragmentation and altered distribution, which is likely causally involved in Ab-induced synaptic abnormalities in neuronal cultures (11, (16) (17) (18) (19) . Studies in Drosophila confirmed Ab-induced changes in mitochondrial dynamics and distribution to be early events in vivo (20, 21) . Abnormal mitochondrial distribution and round, swollen and damaged mitochondria are also documented in Alzheimer's disease mouse models (22, 23) although it remains to be determined whether mitochondria actually fragment or elongate in vivo in Alzheimer's disease mouse models and whether mitochondrial dynamics is causally involved in mitochondrial and neuronal dysfunction in Alzheimer's disease. In this study, we aimed to determine mitochondrial dynamics changes during the progression of disease in CRND8 APP transgenic mice, a widely used Alzheimer's disease mouse model, and explore whether inhibition of mitochondrial fission will alleviate mitochondrial dysfunction and Alzheimer's disease-related deficits in the CRND8 mice to establish the cause-effect relationship in vivo.
Results
Abnormal mitochondrial dynamics and distribution is an early feature in the brain of CRND8 APP Tg mice during the progression of disease To determine mitochondrial morphology and distribution in an Alzheimer's disease mouse model in vivo, we stereotactically injected CRND8 mice with adeno-associated virus (AAV-DJ) expressing mitoDsRed2-P2A-GFP unilaterally into the CA1 region of CRND8 mice and WT littermate control mice (schematic in Fig. 1A ). After 3 weeks to allow sufficient time for protein expression in the CA1 pyramidal neurons, mice were sacrificed at 3 months of age and analyzed for mitochondrial dynamics by confocal microscopy. Imaging studies revealed significantly fragmented and often round shaped mitochondria in CRND8 pyramidal neurons as labeled by mitoDsRed2, which was in marked contrast to more interconnected and filamentous appearance of mitochondria in the pyramidal neurons of WT littermate control mice (Fig. 1B) . Quantitation confirmed that mitochondrial length is significantly reduced (Fig. 1C) and percentage of neurons with fragmented mitochondria is significantly increased in the CA1 area of CRND8 mice (Fig. 1D ). There were also obvious changes in the distribution of mitochondria in the CRND8 pyramidal neurons such that mitochondria became sparse in both soma and axons. This was confirmed by the significantly reduced neurite mitochondrial index (Fig. 1E ) and significantly increased length of segments of axon devoid of mitochondria in the CRND8 neurons (Fig. 1F) . Similar abnormalities in mitochondrial morphology and distribution were found in the pyramidal neurons in 6-month-old CRND8 mice when compared with the age-matched WT littermate controls ( Fig. 1G-K) .
To corroborate our confocal imaging findings, we also performed ultrastructural morphometric study on mitochondrial morphology and distribution in the pyramidal neurons in the cortex of CRND8 mice by electron microscopy (EM). In the pyramidal neurons of the 3-month-old WT littermate control mice, long and thin mitochondria are abundant in both the soma and processes. However, fewer mitochondria, usually shorter and rounder, were found in the cytoplasm of pyramidal neurons of 3-month-old CRND8 mice ( Fig. 2A) . Quantitation analysis confirmed significantly decreased mitochondrial length (Fig. 2B ) and mitochondrial density (Fig. 2C) in the CRND8 neurons. More obvious changes in the distribution of mitochondria in the processes were noted in the CRND8 mice such that mitochondrial density was also significantly reduced in the neuronal processes in CRND8 mice ( Fig. 2A and D) . It is also worth of noting that many mitochondria demonstrated a vacuolated appearance often with an apparently disrupted cristae structure in the CRND8 neurons (Fig. 2E) . Similarly, mitochondria became fragmented and abnormally distributed as reflected by significantly reduced mitochondrial length and significantly reduced mitochondrial density both in the soma and neuronal process in the neurons of 6-month-old CRND8 mice compared with neurons of the agematched WT littermate control mice ( Fig. 2A-D) . More severe cristae damage was also seen in neurons of 6-month-old CRND8 mice (Fig. 2E ).
Mitochondrial dysfunction in the brain of CRND8 APP Tg mice
To determine whether abnormal mitochondrial morphological changes were associated with mitochondrial dysfunction, we first determined the expression of key subunits of the electrontransport chain complexes by western blot analysis using the cocktail antibody (Fig. 3A) . The expression of the subunits of complex III and IV in 3-month-old CRND8 mice was significantly decreased compared with age-matched WT littermate control mice (Fig. 3B) . No significant changes in the expression of complex I and V were noted (Fig. 3B) . Changes in the expression of the key electron transport chain (ETC) proteins would be expected to result in altered mitochondrial respiratory function. The mitochondrial respiration control ratio (RCR) of synaptic mitochondria freshly isolated from the hippocampus of 3-month-old CRND8 mice and WT littermate control mice were measured with Clark oxygen electrode using malate/pyruvate as the substrate. Indeed, synaptic mitochondria from CRND8 mice demonstrated a significant decline in the RCR compared with that of WT littermate control mice (Fig. 3C ).
Abnormal mitochondrial dynamics in the cortical neurons isolated from CRND8 APP transgenic mice: rescuing effects of mitochondrial division inhibitor 1 in vitro
The findings of mitochondrial fragmentation and abnormal distribution along with mitochondrial dysfunction early during the disease progression in CRND8 mice (Figs 1-3 ) prompted us to evaluate the effects of inhibition of mitochondrial fission by treatment with mitochondrial division inhibitor 1 (mdivi-1), a DLP1 inhibitor that was widely used both in vitro and in vivo (24, 25) , in this study. We first tested the efficacy of mdivi-1 in vitro. Primary cortical neurons isolated from E15 brain of CRND8 mice (CRND8 neurons) or their WT littermate control mice (control neurons) were transfected with mitoDsRed2 at days in vitro (DIV) 8 to label mitochondria and imaged/analyzed for mitochondrial morphology at DIV12 (Fig. 4A) . In control neurons, mitochondria were abundant and evenly distributed in the axons and usually displayed short tubular morphology with an average aspect ratio (ratio between major and minor axes of an ellipse equivalent to the mitochondrion as an index for mitochondrial morphology) of 2.27 ( Fig. 4A and B) . In contrast, shorter mitochondria with globular shape were predominantly seen in the axons of the majority of CRND8 neurons which resulted in significantly reduced aspect ratio suggestive of mitochondrial fragmentation ( Fig. 4A and B) . Consistently, there were significantly increased percentage of neurons with Representative EM micrographs demonstrated mitochondria with intact cristae in the WT littermate control mice. However, many mitochondria with a vacuolated appearance and disrupted cristae were apparent in the 3-month-old CRND8 mice (marked by *) and more severe cristae damage was noted in the 6-month-old CRND8 mice (marked by *).
fragmented mitochondria in the CRND8 neurons (Fig. 4C ). Mitochondria also became sparse in neuronal processes in CRND8 neuron ( Fig. 4A ) and quantitation analysis revealed that the neurite mitochondrial index was indeed significantly decreased in CRND8 neurons (Fig. 4D ). As expected, mdivi-1 treatment caused mitochondrial elongation in the control neurons. Importantly, mdivi-1 also led to a dose-dependent inhibition of APP-induced mitochondrial fragmentation in the CRND8 neurons (Supplementary Material, Fig. S1 ) and almost completely blocked mitochondrial fragmentation at 100 nM in the CRND8 neurons since the mean aspect ratio of mitochondria was restored to a level comparable to control neurons ( Fig. 4B ) and the percentage of CRND8 neurons with fragmented mitochondria was also significantly reduced ( Fig. 4C) . Interestingly, 100 nM mdivi-1 treatment also increased the abundance of mitochondria in the neuronal process and the neurite mitochondrial index was significantly improved in the CRND8 neurons (Fig. 4D) .
To investigate fast axonal transport of mitochondria, mitochondria movement in the axons was imaged for up to 30 min under fluorescent microscope for time-lapse recordings ( Fig. 4E ). Compared with control neurons, the percentage of moving mitochondria, in both the anterograde and retrograde direction, was significantly reduced in the CRND8 neurons (Fig.  4F ). Mdivi-1 treatment did not change the percentage of moving mitochondria in the control neurons, but significantly increased moving mitochondria in the CRND8 neurons to the levels comparable to control neurons (Fig. 4F ). The velocity of moving mitochondria in both anterograde and retrograde direction was also significantly decreased in CRND8 neurons but rescued by the treatment of mdivi-1 (Fig. 4G) .
Functionally, mitochondria of CRND8 neurons demonstrated significantly reduced mitochondrial membrane potential (MMP) and ATP levels compared with that of control neurons ( Fig. 4H and I), suggesting significant mitochondrial dysfunction. Importantly, mdivi-1 treatment could significantly improve both MMP and ATP levels in the CRND8 neurons ( Fig. 4H and I ). Overall, these data suggest that mdivi-1 could rescue abnormal mitochondria dynamics and function in CRND8 neurons in vitro.
Mdivi-1 rescued mitochondrial deficits in the brain of CRND8 mice
We then asked whether inhibition of mitochondrial fission in vivo could alleviate Alzheimer's disease-related deficits in the CRND8 mice. To this end, 3-month-old CRND8 mice were randomly divided into two groups to receive mdivi-1 or vehicle treatment for 3 months. We first evaluated the effect of mdivi-1 on mitochondrial morphology in the brain of CRND8 mice after treatment. Mitochondria were stained by COX-1 and imaged/analyzed under the confocal microscope (Fig. 5A ). Quantitative morphological analysis confirmed that when compared with the typically fragmented and round shaped mitochondria in the vehicle-treated CRND8 group, mitochondria became more filamentous in the mdivi-1 treated CRND8 mice and indeed the mean mitochondrial length was significantly increased after mdivi-1 treatment (Fig. 5B ). The percentage of neurons with fragmented mitochondria was also significantly decreased in the mdivi-1 treated CRND8 mice (Fig. 5C ). Similar to the in vitro study, the mitochondrial density was increased in the neuronal processes as evidenced by significantly increased neurite mitochondrial index in the mdivi-1 treated CRND8 mice (Fig. 5D) . The more even mitochondrial distribution was also reflected by significantly reduced average length of neurite segments devoid of mitochondrial presence in the mdivi-1 treated CRND8 mice (Fig. 5E ).
Western blot analysis was also performed to determine the expression of key subunits of the ETC complexes with the oxidative phosphorylation (OXPHOS) cocktail antibody (Fig. 5F ). At 6 months of age, the expression of complex III, IV and V was significantly decreased in the brain of CRND8 mice compared with WT littermate control mice (Fig. 5F) . Interestingly, the mdivi-1 treatment almost completely rescued the expression of these key subunits in the CRND8 mice (Fig. 5F ), suggesting the alleviation of mitochondrial deficits by mdivi-1 treatment in the CRND8 mice.
Mdivi-1 reduced amyloid pathology, b-cleavage of APP and Ab production in the CRND8 mice
To determine the effects of mdivi-1 on Ab accumulation and deposition in the brain of CRND8 mice, immunohistochemical study using the 82E1 antibody against Ab residue 1-16 was performed. Abundant amyloid plaques were present in 6-monthold CRND8 mice without mdivi-1 treatment, while much fewer amyloid plaques were found in the CRND8 mice treated with mdivi-1 (Fig. 6A, top) . Quantification of tissue area occupied by the amyloid plaques as an index for amyloid load confirmed a significant reduction in amyloid deposition (P < 0.05; Fig. 6B ) in (H) and ATP levels (I) were analyzed in cultured neurons at DIV11 after Mdivi-1 treatment. Data are means 6 S.E.M. of three independent experiments, One-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test. *P < 0.05, **P < 0.01, ***P < 0.001. CRND8 mice after mdivi-1 treatment. Given the important role of oligomeric Ab in Alzheimer's disease, we also measured the effect of mdivi-1 on the accumulation of oligomeric Ab by utilizing the NU2 antibody that specifically detects Ab oligomers (Fig. 6a, bottom) and found that mdivi-1 treatment also led to significantly reduced Ab oligomer deposition in the brain of CRND8 mice (Fig. 6C) .
The levels of both soluble and GuHCl-extracted Ab 1-42 and (26) . Western blot analysis of cortical homogenates revealed that mdivi-1 has no effects on the expression level of APP, but caused significantly reduced levels of b-CTF in the treated CRND8 mice (Fig. 6J) . These data indicated that mdivi-1 treatment caused reduced cleavage of APP by b-secretase.
Mdivi-1 improved cognitive function and rescued synaptic deficits in CRND8 mice
To test the effects of mdivi-1 treatment on memory, we analyzed spatial working memory of the CRND8 mice using the spontaneous alternation task in the Y-maze apparatus at the end of the mdivi-1 treatment. Notably, mdivi-1 treated CRND8 mice showed significantly increased spontaneous alternation rate compared with vehicle-treated CRND8 mice (Fig. 7B) , suggesting that mdivi-1 improved memory deficits in CRND8 mice. The total number of arm entries during the Y-maze testing was not significantly different between the mdivi-1 and vehicle treated CRND8 mice (Fig. 7A) , demonstrating that the level of exploratory activity was not affected by the mdivi-1 treatment.
Early changes in the Alzheimer's disease brain include loss of synapses and synaptic loss is the most robust correlate of Alzheimer's disease associated cognitive deficits (27) . Consistent with an improved cognitive function in mdivi-1 treated CRND8 mice, immunocytochemical analysis of antibody to synaptophysin revealed increased levels of synaptophysin in the CRND8 mice treated with mdivi-1 compared with those without mdivi-1 treatment (Fig. 7C and D) . Indeed, western blot analysis also confirmed a significant increase in the expression of synaptophysin in the mdivi-1 treated CRND8 mice compared with vehicle treated CRND8 mice (Fig. 7E) , suggesting a synaptoprotective effect of mdivi-1 in the CRND8 mice. was used as an internal loading control. Data are means 6 S.E.M. Student's t-test. *P < 0.05, **P < 0.01.
Mdivi-1 reduced Alzheimer's disease-related pathological changes in CRND8 mice
Oxidative stress is a prominent early feature in Alzheimer's disease (28) . We compared the oxidative stress in CRND8 mice with/without mdivi-1 treatment. Immunocytochemical analysis of antibody to DNP, a widely used oxidative marker for protein oxidation, revealed significantly reduced neuronal DNP immunoreactivity in the brain of mdivi-1 treated CRND8 mice compared with vehicle-treated CRND8 mice (Fig. 8A and B) . Antibody to heme oxygenase 1 (HO-1) , an inducible isoform of GAPDH was used as an internal loading control. Data are means 6 S.E.M. Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001. antioxidant enzyme, instead revealed significantly increased immunoreactivity in the mdivi-1 treated CRND8 mice ( Fig. 8C  and D) .
Discussion
In this study, we demonstrated significant mitochondrial fragmentation and abnormal mitochondrial distribution in the pyramidal neurons of CRND8 APP transgenic mice as early as 3 months of age before the accumulation of amyloid pathology. This was accompanied by reduced expression of key subunits of the mitochondrial ETC complexes and respiratory dysfunction of synaptic mitochondria in the CRND8 mice. The inhibition of mitochondrial fission by the treatment of mdivi-1, a DLP1 inhibitor (25), could rescue both mitochondrial morphology and distribution deficits and the expression of mitochondrial ETC proteins in the brain of CRND8 mice. Importantly, the restoration of mitochondrial dynamics by the mdivi-1 treatment led to the rescue of cognitive impairment, reduction of amyloid pathology and increase of synaptic markers in the CRND8 mice, demonstrating that mdivi-1, by inhibiting fission and thus restoring mitochondrial dynamics in CRND8 mice, could alleviate Alzheimer's disease-related pathological and functional deficits in vivo.
One important finding of the current study is the abnormal change in mitochondrial morphology that is consistent with significant mitochondrial fragmentation in the pyramidal neurons in the hippocampus and cortex of 3-month-old CRND8 mice. Abnormal mitochondrial distribution in these neurons was also noted such that the mitochondrial density in both the soma and neuronal processes was significantly reduced. This was first demonstrated by confocal microscopy where mitochondria were labeled by the expression of mitoDsRed2 fluorescent protein and further confirmed by EM. This is consistent with findings in the in vitro cell model of Alzheimer's disease where overexpression of familial Alzheimer's disease-causing APP mutations in neuronal cells caused extensive mitochondrial fragmentation and abnormal mitochondrial distribution as reflected by perinuclear accumulation or depletion of neuritic mitochondria in vitro. It has been suggested that APP overexpression induced abnormal mitochondrial dynamics likely through the increased production of Ab since APP-induced effects were abolished by Beta-secretase 1 (BACE-1) inhibitor and Ab treatment elicits similar mitochondrial dynamics changes in cultured neuronal cells (11, (16) (17) (18) (19) . Along this line, a prior study, by using multiphoton microscopy for intravital imaging to evaluate mitochondrial structure, demonstrated fragmented mitochondria only in the vicinity of dense core plaques in 7-to 10-month-old APP/presenilin 1 (PS1) mice with abundant amyloid pathology (29) which implicated that mitochondrial dynamic changes are likely a late event secondary to the extensive amyloid pathology. However, we found in the current study that abnormal mitochondrial dynamics was apparent in the 3-month-old CRND8 mice before the accumulation of amyloid pathology which clearly indicated that abnormal mitochondrial dynamics is an early event that may contribute to the development and accumulation of amyloid pathology. A likely reason for the discrepancy was different neuronal population investigated in these two studies: we studied hippocampal neurons which are vulnerable to Alzheimer's disease-related deficits while the multiphoton microscopy study during in vivo imaging, due to the limitation of depth penetration, was restricted to neurons in the near-surface area of the cerebral cortex which may be less vulnerable. Such a notion is supported by another study focusing on the hippocampal neurons in the same APP/ PS1 mice using three-dimension EM which reported abnormal mitochondrial morphology in 2-to 3-month-old APP/PS1 mice, also before the plaque development (22) . Interestingly, this latter study revealed a peculiar 'beads-on-the-string' morphology of mitochondria that led to increased mitochondrial length in the APP/PS1 mice (22) . Despite the increased mitochondrial length, the observation of small mitochondria connected by thin membranous structure most likely reflected enhanced fission which out of unknown reasons became arrested (or much slower) at the final scission step instead of enhanced fusion (23) . We occasionally noted two mitochondria remaining connected in the electron micrographs in both CRND8 and WT littermate controls mice (not shown). Altogether, our study provided new evidence to support an early role of mitochondrial fragmentation in the course of disease in vivo.
Accompanying abnormal mitochondrial dynamics, mitochondrial dysfunction was also found in the 3-month-old CRND8 mice as evidenced by significantly reduced expression of key subunits of the ETC complexes and the impaired respiration of the synaptic mitochondria. This is consistent with the previous study demonstrating early deficits in synaptic mitochondria in another Alzheimer's disease mouse model (19) . To explore the causal relationship between mitochondrial early dynamics changes and mitochondrial dysfunction in Alzheimer's disease mouse mode, we treated CRND8 mice with mdivi-1 to inhibit mitochondrial fission in vivo. Mdivi-1 effectively inhibits mitochondrial fission by preventing the mitochondrial translocation of DLP1 (25) . Recent studies demonstrated that mdivi-1 crossed the blood-brain barrier and inhibited mitochondrial fission in the brain (24, 30) . Indeed, we found that mdivi-1 treatment rescued mitochondrial morphology and distribution in CRND8 neurons both in vitro and in vivo. Importantly, mdivi-1 treatment further led to the rescue of mitochondrial functional deficits in CRND8 neurons such as the restoration of ATP production and mitochondrial membrane potential in vitro and the expression of key subunits of ETC complexes in the brain of CRND8 mice, thus establishing a causal role of mitochondrial fragmentation in mitochondrial dysfunction in CRND8 neurons. It is not entirely clear though how mitochondrial fragmentation causes mitochondrial dysfunction in the CRND8 neurons. One possible mechanism is that excessive mitochondrial fission may cause changes to the curvature of cristae membrane that could impact the assembly of ETC complexes and supercomplexes and affect their stability and activity (31, 32) . In this regard, destabilization of complex V was recently reported in the mitochondria from 5xFAD mice (33) . Excessive mitochondrial fission may also damage the structure and the integrity of mitochondrial membrane such as the loss of intact cristae structure in Mfn2 knockout neurons (34) and cause mitochondrial dysfunction. Alternatively, changes in mitochondrial dynamics could impact mitochondrial homeostasis and function through alterations in mitophagy (35) which is also known to be changed in Alzheimer's disease (36) .
In addition to the restoration of mitochondrial dynamics and improvement of mitochondrial function, mdivi-1 treatment also rescued cognitive function, reduced amyloid pathology and improved synaptic deficits in the CRND8 mice. It must be acknowledged that we only used a simple Y-maze test to assess the spatial working memory and found that mdivi-1 significantly improved the spontaneous alternation rate in the CRND8 mice, suggesting that mdivi-1 improved the cognitive in this model, likely through the improvement in mitochondrial dynamics and function. It would be desired if additional cognitive/ behavioral tests are performed to confirm the beneficial effects of mdivi-1 on AD-related cognition in APP transgenic models. Mdivi-1 significantly reduced dense core plaques and oligomeric Ab deposits in the brain of CRND8 mice, likely a direct result from reduced b-CTF production and reduced Ab 1-42 /Ab 1-40 ratio, reflecting the modulation of BACE-1 activity. It has been reported that oxidative stress enhances BACE-1 expression and activity (37, 38) , mdivi-1 treatment reduced oxidative damage and enhanced antioxidant response in the brain of CRND8 mice which could have beneficial effects on BACE-1 mediated b-cleavage of APP protein. It is worth noting that mdivi-1 had more dramatic effects on the change in the soluble Ab and reversed intraneuronal Ab accumulation more completely which is perhaps more relevant to the improvement of cognitive function. On the other hand, proper mitochondrial distribution is critical for synaptic function in cultured neurons and in drosophila models (5, 39) . CRND8 mice demonstrated reduced mitochondrial density in the neuronal processes, leaving large segments of neurites devoid of mitochondria coverage, which correlated with reduced synaptophysin signal. Mdivi-1 rescued mitochondrial distribution in the neurites and increased synaptophysin signal which likely also contributes to the improvement of cognitive function. These findings support the notion that abnormal mitochondrial dynamics plays an early and causal role in the mitochondrial dysfunction and Alzheimer's disease-related pathological and cognitive impairments in vivo and demonstrated abnormal mitochondrial dynamics as a potential therapeutic target for future drug development for Alzheimer's disease.
Materials and Methods
Animals, mdivi-1 treatment and Y-maze test CRND8 mice were obtained from University of Toronto and a breeding colony has been maintained at Case Western Reserve University. Mdivi-1 was obtained from Enzo and dissolved in Dimethyl sulfoxide (DMSO, Sigma Aldrich). CRND8 mice and wild-type (WT) littermate controls received an intraperitoneal (i.p.) injection of Mdivi-1 (1.5 mg/30 g body weight) once per 2 weeks for 3 months starting at age of 3 months. Three months after Mdivi-1 treatment, animals were subject to Y-maze test for short-term working memory. Spontaneous alternation performance was assessed by an opaque plastic 3-arm Y-maze under reduced light conditions. Each arm was 30-cm long and 7-cm wide with transparent walls (15-cm high). Individual mice were randomly placed in one of the three arms and allowed 8-min free exploration. The number and the sequence of visited arms were recorded. The two main parameters measured were the number of arms entered and percent alternation, calculated as the number of alternations divided by the total possible alternations and multiplied by 100. Animals were sacrificed after testing and brain tissues were collected for analysis.
AAV production, brain stereotaxic injection and cryosectioning
Adeno-associated viruses were generated by AAV helper free systems (Cell Biolabs). Briefly, AAV-293 cells were transfected with three plasmids: pHelper, pAAV-DJ Rep-Cap and pAAVmito-DsRed-p2a-GFP. Three days after transfection, cells were harvested and viruses were purified by AAV Purification Kit (Clonetech). Animals were anesthetized using isoflurane and placed in a stereotactic frame. A small incision was made to expose the skull surface and to visualize bregma. Holes were drilled in the skull overlying the dorsal hippocampus, CA1 (AP À2.1, ML À2.0 from the bregma). A 10-ll microsyringe (Hamilton) was filled with virus and the needle was lowered down 1.4 mm from the bregma. One microliter virus (10 10 viral particles/ml) was injected within 5 min and the needle left in place for another 5 min before slowly withdrawing it. The skin was sutured and mice were monitored and recovered on a warm pad. Three weeks after virus injection, mice were deeply anesthetized with avertin and transcardially perfused with cold PBS for 4-5 min. The brain was dissected out and immersionfixed in 10% paraformaldehyde for 24 h and then in 30% sucrose in PBS until the tissue sank to the bottom. Then the brain was frozen in À80 C and coronal sections were cut in 20 lm by cryostat (Leica). Sections were air-dried in À20 C overnight and returned back to room temperature for rehydration in PBS. Then sections were stained with DAPI for nuclei and mounted with No.1.5 cover glass (VWR) and Fluoromount-G mounting medium (Southern Biotech) for imaging.
Cortical neuron culture and time-lapse imaging
Mouse cortices were isolated from embryo at embryonic Day 15 (E15). Isolated tissues were digested in 0.25% trypsin (Invitrogen) for 15 min at room temperature. Then tissues were triturated no more than 15 times with 1 ml tips in 37 C warmed
Neurobasal medium (Gibco) with 10% FBS and DNAse I (50 units/ml, Worthington-Biochem). Neurons were seeded at 10 6 cells per 35 mm petri dish coated with poly-D-lysine in Neurobasal medium supplemented with 2% B27/1% GlutaMAX (Invitrogen). All cultures were kept at 37 C in a humidified 5% CO 2 incubator. At DIV7, neurons were transfected with mitoDsRed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol for live imaging. Two days after transfection, neurons in culture were placed in a chamber with humid 5% CO 2 at 37 C and imaged by an inverted Leica DMI6000 fluorescence microscope (Leica) with a 20Â/0.7 NA objective. During time-lapse imaging, frames were collected every 10 s for 0.5 h without phototoxicity or photobleaching. Kymograph of mitochondria movement was generated by MultipleKymograph in ImageJ. Mitochondrial movement was analyzed by Difference tracker (40) with ImageJ.
Mitochondria isolation and oxygen consumption assay
Mouse cortical tissues were rinsed in ice-cold MSM (220 mM D-mannitol, 70 mM sucrose, 5 mM MOPS, pH 7.4) and incubated 30 s with Protease Subtilin A (5 mg/gm tissue) and EDTA (2 mM) in MSM. Tissues were homogenized with loose-fitting pestle.
Homogenates were centrifuged at 10 000 rpm for 10 min. The pellet was re-suspended in 0.2% BSA in MSM and centrifuged at 500g for 10 min, and supernatant saved. Pellets were finally resuspended in $0.2 ml MSM. Oxygen consumption in mitochondria was measured using a Clark-type oxygen electrode at 30 C (41). Mitochondria were incubated in solution including 80 mM KCl, 50 mM MOPS, 1 mM EGTA, 5 mM KH 2 PO4 and 1 mg/ml bovine serum albumin at pH 7.4 in a volume of 0.5 ml. Pyruvate and malate were used as substrate, and respiratory control ratios were determined by respiratory activity of state 3/state 4.
Western blot and biochemical measurement
Brain tissues were homogenized by glass homogenizer on ice in RIPA buffer (Abcam) with protease inhibitor (Cell signalling). Tissue homogenates were centrifuged at 18 000g for 10 min and supernatants were aliquoted and stored at À80 C for western blot analysis. A total of 30 mg protein samples were subject to 10% SDS-PAGE and proteins were transferred to PVDF 
ELISA measurement of Ab
Brain tissues were homogenized by glass homogenizer on ice and sequentially extracted in with TBS buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl) and 5 M guanidine HCl buffer as described (42) . 
Immunocytochemistry, confocal immunofluorescence and EM
Immunocytochemistry was performed by the peroxidase antiperoxidase protocol (43) . Formalin fixed paraffin embedded sagittal brain samples were sectioned at 6 mm thickness. Serial sections were obtained spanning the entire hippocampal regions and five sections at least 150 lm apart were immunostained for amyloid burden quantification. Amyloid deposition was detected by anti-amyloid antibody 82E1 (IBL) and anti-amyloid oligomers (NU2, gift of William Klien). Antibodies for HO-1 (Enzo) and the DNP assay for protein carbonyls were used for oxidative stress measurement. For immunofluorescence staining, 6-mm paraffin sections slides were incubated sequentially in Xylene I, Xylene II, 100% Etho, 90% Etoh, 75% Etho and 50% Etho for 5 min in each solution. Deparaffinized and re-hydrated tissue sections were washed with PBS three times, and the sections were then subject to antigen retrieval in 1Â antigen decloaker (Biocare Concord). After blocking by 10% normal goat serum (NGS) in PBS, sections were stained by OXPHOS rodent antibody cocktail (Abcam) and synaptic marker was stained by anti-synaptophysin (Invitrogen) overnight in a humid chamber at 4 C. After three washes with PBS, the sections were incubated in 10% NGS for 10 min, and then with Alexa Fluor conjugated secondary antibody (Life Technologies) (1:300) for 2 h at room temperature protected from light. Finally, the sections were rinsed three times with PBS, stained with DAPI for nuclei, washed again with PBS for three times and mounted with NO.1.5 cover glass (VWR) and Fluoromount-G mounting medium (Southern Biotech). Confocal images were collected by Leica TSC S8 platform with an inverted DMI 6000 adaptive focus microscope. Electron microscopic analysis was performed as previously described. Taken briefly, mouse brains were perfused with EM fixative (the quarter strength Karnovsky-1.25% DMSO mixture) and tissue blocks of the same cortical regions were post-fixed in 1% osmium-1.25% ferrocyanide mixture. Then specimens were dehydrated in ascending concentrations of ethanol, and embedded in Poly/Bed 812 embedding resin (Polysciences, Warrington, PA, USA). Thin sections were sequentially stained with 2% acidified uranyl acetate followed by Sato's triple lead staining and examined in an FEI Tecnai T12 electron microscope equipped with a Gatan single tilt holder and a CCD camera (Gatan, Pleasanton, CA, USA). At least two mice from each group were analyzed and four to five neurons showing the neuronal soma with long post-hillock process regions were imaged from each mouse. Age and genotype were blinded to the microscopist. Using ImageJ software, every individual mitochondria was measured for length and area. Mitochondria in the soma and post-hillock process were measured separately. Cytoplasmic area only (i.e. not containing nucleus) of the soma and post-hillock process were also measured.
Statistical analysis
All these data were independently assessed and collected by investigators without prior knowledge of samples. Statistical analysis was done with one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test or Student's t test. Data are means 6 S.E.M. P < 0.05 was considered to be statistically significant. n.s., not significant. Data were normally distributed with similar variance between the groups. All statistical analyses were performed blindly.
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